海外行/凝心聚力，康体生命美国波士顿分公司正式成立

为了实现加速响应客户需求、“零距离”技术服务、无障碍沟通、缩短交付时间等目的，康体生命建立了一支本地化专业团队，并整合、优化当地资源，为客户提供纳米抗体和GPCR靶点膜蛋白的技术开发方案。同时，分公司与当地多个合作伙伴建立深度协作关系，不断开拓北美市场。康体生命美国分公司负责人Mr.Du表示：“美国团队能够为北美乃至全球客户提供优质、可靠、诚信、高效的GPCR纳米抗体定制研发及功能验证一站式解决方案平台。

In order to achieve the purpose of faster response to customer needs, “zero distance” technical services, barrier-free communication. And shortening delivery time, AlpaLifeB has established a local & professional team. “The U.S. team can offer the worldwide market with high-quality products, realizable services, and efficient one-stop nanobody discovery platform. We are dedicated to support novel nanobody/VHH and GPCR-targeted drug development.” Said by Mr.Du, head of the AlpaLifeB Inc.